BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Aragen Life Sciences Ltd. IPO

Objective

1.Repayment and/or pre-payment, in part or full, of certain borrowings availed by our Company and our Material Subsidiaries;
2.Capital expenditure to be incurred by the Company for purchase of new equipment and machinery for the facilities in Hyderabad;
3.Capital expenditure to be incurred by one of our Material Subsidiaries, namely, Aragen Biologics Private Limited for the facility in Bengaluru towards purchase of new equipment and machinery for the following: a.Expansion of biologics drug substance capacity (“Drug Substance Expansion”); and b.Establishment of biologics drug product fill and finish capability (“Fill and Finish Line Establishment”); and
4.General corporate purposes

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 0.00 - 0.00 Cr
Price Band ₹ 0.00 - ₹ 0.00 Per Share
Issue Type Book building

About Company

We are a fully integrated contract research, development and manufacturing organization (“CRDMO”) serving global innovator companies and emerging firms in the life sciences industry. We offer comprehensive solutions across the entire drug development lifecycle spanning contract discovery and pre-clinical research solutions (“CRO” or “Contract Research”) and contract development and manufacturing solutions (“CDMO”) for both small molecules and biologics. With more than 25 years of operations, we have become the largest CRDMO among the assessed Indian peers in terms of number of solutions offere .... d across the drug development value chain as of March 31, 2026 (Source: F&S Report). We have become one of the top three largest Indian CRDMOs in terms of operating revenue among the assessed Indian peers, operating in a global CRDMO market estimated at USD 171 billion in Fiscal 2026 (Source: F&S Report). Our platform focuses on life sciences companies that are engaged in new chemical entities (“NCEs”) and new biological entities (“NBEs”) and we served as a strategic partner to 591 customers globally in Fiscal 2026, across key markets including the United States, Europe, Japan, India and other APAC markets. Our customer base comprises Big Pharma companies, large pharmaceutical companies, small / biotechnology companies and mid-sized pharmaceutical companies operating across pharmaceuticals, biotechnology, animal health, agrochemicals and specialty chemicals. We worked with 16 of the Top 20 Big Pharma customers as of March 31, 2026 (Source: F&S Report). We also recorded the second highest revenue from operations growth between Fiscal 2025 and Fiscal 2026 among the assessed Indian peers, according to the F&S Report. Read More
Address

Plot 28 A Ida Nacharam

City

Hyderabad

State

Telangana

Pincode

500076

Phone

040-66929989

Email

compliances@aragen.com

Website

www.aragen.com

About IPO

Listed At BSE/NSE
Lead Manager JM Financial Consultants Pvt Ltd
Promoters
Davinder Singh Brar
Reddy Investment Trust
Aparna Reddy Gunapati
Keshav Gunupati Venkat Reddy
Madhubani Investments Pvt Ltd.

Promoter's Holding

Registrar

KFIN Technologies Ltd.

Latest News

Sep
21
2026
EQUITY Posted on Sep 21st 2026

Garment Mantra Lifestyle informs about monthly business updates

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereof, Garment Mantra Lifestyle has informed that the Company has received an order from Zaara Overases F.Z.E. for ~103.70 Million Rs. (10,80,920 USS). Details as per SEBI Circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure A. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Magellanic Cloud informs about purchase order

Magellanic Cloud has informed that Provigil Surveillance, a wholly owned subsidiary of the company, has received a Purchase Order from Nayara Energy, valued at Rs. 44,60,400/-. The Purchase Order is for the implementation of an AI-powered Automatic Number Plate Recognition (ANPR) and Video Analytics Platform across selected Retail Outlets and Oil Depots of Nayara Energy. The aforesaid Purchase Order has been awarded in the ordinary course of business of the Company and is aligned with its core business of providing integrated surveillance, security and technology solutions. The Company remains committed to executing the project with the highest standards of quality, efficiency and operational excellence while continuing to pursue similar opportunities across the energy, transportation, government and critical infrastructure sectors.

The above information is a part of company’s filings submitted to BSE.

Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Hy-Tech Engineers informs about press release and investor presentation

Pursuant to requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hy-Tech Engineers has informed that it enclosed a copy of the Press Release along with the Investor Presentation for the Unaudited Financial Results for the quarter ended June 30, 2026. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Urban Company informs about analyst meet

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Urban Company has informed that the Company will be meeting with Analyst(s)/ Investor(s) ‘New Vernon’ on September 21, 2026 (One on one). No unpublished price sensitive information pertaining to the Company is/ shall be shared at the aforesaid Investor meeting. The aforesaid details will also be hosted on the Company's website: https://investorrelations.urbancompany.com/. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Escorts Kubota informs about appointment of change in management

In compliance with Regulation 30 read with Para A (7) of Part A of Schedule III of SEBI Listing Regulations, Escorts Kubota has informed that, Manish Sharma has been appointed as ‘President-Agri Business’ (Senior Management Personnel) of the Company with effect from September 21, 2026. The requisite disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025CFDPOD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure I. The date and time of occurrence of the event is September 21, 2026, at 09:00 A.M.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Aragen Life Sciences Ltd. IPO?

The issue size of Aragen Life Sciences Ltd. IPO is ₹0.00 - 0.00 crore.

The Aragen Life Sciences Ltd. IPO opens for subscription on and closes on .

The price range of Aragen Life Sciences Ltd. IPO is ₹0.00 to ₹0.00.

The lot size of Aragen Life Sciences Ltd. IPO is shares.

The registrar of Aragen Life Sciences Ltd. IPO is KFIN Technologies Ltd..

Aragen Life Sciences Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before to increase your chances.

The listing date of Aragen Life Sciences Ltd. IPO is .

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore